Dopamine AntagonistsDopamineReceptors, Dopamine D2DomperidoneReceptors, DopamineReceptors, Dopamine D1Dopamine AgonistsMetoclopramideHaloperidolSpiperoneFlupenthixolPimozideReceptors, Dopamine D3SulpirideBenzazepinesTrifluperidolButaclamolFluphenazineDopamine Plasma Membrane Transport ProteinsButyrophenonesBromocriptineDopamine AgentsTiapamil HydrochlorideErgotismErgolinesReceptors, Dopamine D5Dopamine Uptake InhibitorsAcremoniumDopamine beta-HydroxylaseCorpus StriatumProlactinRats, Sprague-DawleyFanconi AnemiaBehavior, AnimalDose-Response Relationship, DrugQuinpiroleRacloprideNucleus AccumbensSalicylamidesApomorphineCocainePyrantel TartrateLevodopaRats, Inbred StrainsEryngiumDopaminergic NeuronsPregnadienediolsHomovanillic AcidTyrosine 3-MonooxygenaseKorsakoff SyndromeSubstantia NigraVentral Tegmental AreaNeuronsOxidopamineMesencephalonExcitatory Amino Acid AntagonistsMotor ActivityCaudate NucleusSerotoninHormone Antagonistsalpha-MethyltyrosineTropanesNarcotic AntagonistsBrainNomifensineDihydroxyphenylalanineRewardRats, WistarNorepinephrineVesicular Monoamine Transport ProteinsPiperidinesMethamphetamineNeurokinin-1 Receptor AntagonistsPutamenRadioligand AssayGABA AntagonistsNicotinic AntagonistsBiogenic MonoaminesMuscarinic AntagonistsHistamine H2 AntagonistsDrug InteractionsPyrrolidinesSynaptic TransmissionPrefrontal CortexInterleukin 1 Receptor Antagonist ProteinPiperazinesAdenosine A2 Receptor AntagonistsCentral Nervous System StimulantsCatecholaminesParkinsonian DisordersTime FactorsReserpinePurinergic P1 Receptor AntagonistsSelf AdministrationElectric StimulationAnalysis of VarianceStereotyped BehaviorHistamine H1 AntagonistsConditioning, OperantAntiparkinson Agents